Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Revisting Fractionated Urine Porphyrins Analysis and its Utility in Diagnosing Non-porphyrias

SIMD 2024

Society for Inherited Metabolic Disorders

Charlotte, NC, April 14-17, 2024

Poster presentation: Revisting Fractionated Urine Porphyrins Analysis and its Utility in Diagnosing Non-porphyrias

Authors: Peretz R, Salazar D, Tanpaiboon P

Specialty: Genetics

Related content

Publication
Biochemical Diagnosis of Acute Hepatic Porphyria Updated Expert Recommendations for Primary Care Physicians
Conference Presentation
The Dual Laboratory Faces of Porphyria Cutanea Tarda
Test FAQ
Porphyria Testing
Publication
Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.